Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Insamo Launches with $12M Funding from Playground Global, venBio, and MRL Ventures Fund to Develop Best-in-Class Membrane-Permeable Macrocyclic Peptides
Life Sciences Times
-
February 21, 2024
0
Venture Capital
Reprieve Cardiovascular Emerges from Stealth Mode after $42 Million Series A Financing to Bring Intelligent Fluid Management to Heart Failure Patients
Life Sciences Times
-
February 20, 2024
0
Venture Capital
Cagent Vascular Raises $30 Million Series C Financing
Life Sciences Times
-
February 20, 2024
0
Venture Capital
Merit Medicine Announces $2M Seed Round to Transform Employer-Sponsored Healthcare with AI-Powered Risk Predictions
Life Sciences Times
-
February 15, 2024
0
Venture Capital
NextPoint Therapeutics Announces Closing of Series B Financing Extension Led by Catalio Capital Management
Life Sciences Times
-
February 14, 2024
0
Venture Capital
Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics
Life Sciences Times
-
February 12, 2024
0
Venture Capital
Aizon Secures $20M in Series C Funding Led by NewVale Capital to Enhance Pharma Manufacturing Outcomes
Life Sciences Times
-
February 8, 2024
0
Venture Capital
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
Life Sciences Times
-
February 7, 2024
0
Venture Capital
Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
Life Sciences Times
-
February 7, 2024
0
Venture Capital
Leading Neuroscientists Bring Elemind Out of Stealth, Close $12 Million Seed Round for AI-enhanced Neurotech Wearable
Life Sciences Times
-
February 6, 2024
0
Venture Capital
Vektor Medical Secures $16 Million Series A Funding
Life Sciences Times
-
February 5, 2024
0
Venture Capital
Synchron Acquires Equity Stake in ACQUANDAS
Life Sciences Times
-
February 1, 2024
0
1
...
34
35
36
...
115
Page 35 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026